Young doctor working

FAQs

How many people does AstraZeneca employ worldwide?

We employ around 51,700 people:

  • 45.6% in Europe;
  • 27.8% in the Americas
  • 26.6% in Asia-Pacific

How many shares does AstraZeneca have outstanding?

The total number of shares in issue at 30 June 2014 was 1,263 million.

On what stock exchange is AstraZeneca traded and what is the stock symbol?

AstraZeneca is traded on the London, New York and Stockholm stock exchanges. The symbol is AZN in all three markets.

What accounting convention does AstraZeneca adhere to?

AstraZeneca adheres to the International Financial Reporting Standards (IFRS) and International Accounting Standards (IAS) with appropriate conversion to US GAAP being shown in our financial statements.

What is AstraZeneca's current debt rating?

Moody's :
Long term: A2, Short term: P-1, Outlook: Stable
Standard & Poor's :
Long term AA-, Short term A-1+, Outlook: Negative
Fitch :
Long term AA-, Short term F1+, Outlook: Negative

What is AstraZeneca's CUSIP number for its ADRs traded on the New York Stock Exchange?

046353108

What is AstraZeneca's offical accounting currency?

AstraZeneca reports in US dollars.

When is AstraZeneca's next earnings release?

AstraZeneca will announce third quarter and nine months results on Thursday 6 November 2014.

When is AstraZeneca’s next Annual General Meeting?

The date for the 2014 Annual General Meeting will be Thursday 24 April 2014.

When was AstraZeneca PLC formed?

AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of Sweden and Zeneca PLC of the United Kingdom.

Where can I find historical financial information on AstraZeneca?

This information can be found in the financial results section.

When will I receive my next dividend payment?

For information on dividends, please see the Dividend section of the FAQs:

Can AstraZeneca pay my dividends directly into my bank or building society account?

Yes, it is possible to have your dividends paid directly into your bank or building society.

If your shares are held by a broker or nominee please contact them directly.

If you are a registered shareholder please contact the following:

  • UK shareholders should complete the request for payment of dividend form and forward it to Equiniti.
     
  • US shareholders should go to the Investor Services section of the JP Morgan ADR website.
     
  • Swedish shareholders should contact your personal broker or if you hold a VPC account contact the VPC on +46 (0) 8 402 9000, alternatively contact Euroclear.

    Contact details for Equiniti, JP Morgan and Euroclear can be found here.
     

Does AstraZeneca have a dividend re-investment plan?

At present AstraZeneca does not have a dividend re-investment plan.

I am a non-taxpayer; can I have my AstraZeneca dividends paid gross?

No, it is not possible to have your dividends paid gross.

Where can I find dividend information?

Please visit our dividend section.

My personal details have changed - whom do I contact?

Who do I contact to:

- request information on my account?
- transfer stock?
- request a share certificate replacement?

This will depend on where your shares are held:

If your shares are held by a broker or nominee please contact them directly.

If you are a registered shareholder please contact the following:

  • UK shareholders should contact Equiniti.
  • US shareholders should go to the JP Morgan Chase Bank website or call them.
  • Swedish shareholders should contact your personal broker or if you hold a VPC account contact the VPC on +46 (0) 8 402 9000.

    Contact details for Equiniti and JP Morgan can be found here.
     

I am a UK shareholder. How do I allocate my cost basis of AstraZeneca shares to my Syngenta distribution?

Please follow the link below to a summary of dividends paid in the form of Syngenta shares.

View UK cost basis information (PDF 545kb) opens in a new window.

I am a US shareholder. How do I allocate my cost basis of AstraZeneca shares to my Syngenta distribution?

Please follow the link below to a summary of dividends paid in the form of Syngenta shares.

View US cost basis information (PDF 17kb)  opens in a new window.

I still hold Astra AB shares. What course of action should I take?

View a letter to Astra AB shareholders (PDF 5kb)  opens in a new window.

A legal representative, Peter Haglund, has been appointed to act on behalf of minority shareholders. He can be contacted at Advokatfirman Sodermark, Box 14055, SE 104 40 Stockholm, Sweden, telephone +46 8 670 57 50 and fax +46 8 663 67 20.

What was the closing price of AstraZeneca PLC shares on its first trading day?

On 6 April 1999 (the first trading day of AstraZeneca PLC) the closing price was GBP 29.46.

What was the value of Zeneca shares when it demerged from ICI?

Shares in Zeneca Group PLC acquired on demerger from ICI will be treated as having a base cost for capital gains tax purposes ascertained by reference to the values of Zeneca and ICI shares on 1 June 1993 calculated in accordance with the provisions of Section 272 of the Taxation of Chargeable Gains Act 1992. The base cost of any holding of ICI Shares on that date will be adjusted on the same basis.

The relevant prices on The London Stock Exchange on 1 June 1993 were:

Zeneca - 625.75p and ICI - 631.75p

The base cost of the pre-merger ICI Shares were therefore split between the post-demerger Zeneca and ICI Shares in the following proportions:

Zeneca - 0.49761 and ICI - 0.50239
 

 

 

When Astra AB and Zeneca Group PLC merged how were the shares split / merged?

Astra AB and Zeneca Group PLC shares were merged on 6th April 1999.
1 Astra share : 0.5045 AstraZeneca share
1 Zeneca share : 1 AstraZeneca share

When did AstraZeneca demerge its agrochemical business?

AstraZeneca demerged its agrochemical business on 13 November 2000.